Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Cantor Fitzgerald
Julphar
Fuji
Teva
Queensland Health
Healthtrust
Fish and Richardson

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Eleclazine

« Back to Dashboard

US Patents for Eleclazine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Eleclazine ➤ Sign Up Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Eleclazine ➤ Sign Up Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Eleclazine ➤ Sign Up Methods of treating hypertrophic cardiomyopathy Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Eleclazine ➤ Sign Up Compound and methods for treating long QT syndrome Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Eleclazine ➤ Sign Up Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Eleclazine ➤ Sign Up Solid forms of an ion channel modulator Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Eleclazine

Drugname Country Document Number Estimated Expiration Related US Patent
Eleclazine Argentina 086828 2031-07-01 ➤ Sign Up
Eleclazine Argentina 086829 2031-07-01 ➤ Sign Up
Eleclazine Australia 2012279214 2031-07-01 ➤ Sign Up
Eleclazine Australia 2012279236 2031-07-01 ➤ Sign Up
Eleclazine Australia 2013201608 2031-07-01 ➤ Sign Up
Eleclazine Brazil 112013032027 2031-07-01 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army
Farmers Insurance
Cerilliant
AstraZeneca
Fish and Richardson
Cipla
Argus Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.